https://ir.definiumtx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_354426f606269984c271309319e3bc85/mindmed/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.definiumtx.com/news-events/press-releases/detail/236/definium-therapeutics-announces-new-employee-inducement-grants Mon, 06 Jul 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/236/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/235/definium-therapeutics-inc-announces-closing-of-805-million-upsized-public-offering-including-full-exercise-of-the-underwriters-option-to-purchase-additional-shares Thu, 25 Jun 26 16:15:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/235/definium-therapeutics-inc-announces-closing-of-805-million-upsized-public-offering-including-full-exercise-of-the-underwriters-option-to-purchase-additional-shares https://ir.definiumtx.com/news-events/press-releases/detail/234/definium-therapeutics-inc-announces-pricing-of-700-million-upsized-public-offering Tue, 23 Jun 26 21:57:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/234/definium-therapeutics-inc-announces-pricing-of-700-million-upsized-public-offering https://ir.definiumtx.com/news-events/press-releases/detail/233/definium-therapeutics-inc-announces-proposed-public-offering Mon, 22 Jun 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/233/definium-therapeutics-inc-announces-proposed-public-offering https://ir.definiumtx.com/news-events/press-releases/detail/232/definium-therapeutics-announces-positive-topline-results-from-phase-3-emerge-study-of-dt120-orally-disintegrating-tablet-odt-in-major-depressive-disorder Mon, 22 Jun 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/232/definium-therapeutics-announces-positive-topline-results-from-phase-3-emerge-study-of-dt120-orally-disintegrating-tablet-odt-in-major-depressive-disorder https://ir.definiumtx.com/news-events/press-releases/detail/231/definium-therapeutics-to-discuss-topline-results-from-phase-3-emerge-study-in-major-depressive-disorder-on-june-22-2026 Sun, 21 Jun 26 17:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/231/definium-therapeutics-to-discuss-topline-results-from-phase-3-emerge-study-in-major-depressive-disorder-on-june-22-2026 https://ir.definiumtx.com/news-events/press-releases/detail/230/definium-therapeutics-announces-new-employee-inducement-grants Mon, 15 Jun 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/230/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/229/definium-therapeutics-announces-new-employee-inducement-grants Mon, 01 Jun 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/229/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/228/definium-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference Thu, 21 May 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/228/definium-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference https://ir.definiumtx.com/news-events/press-releases/detail/227/definium-therapeutics-announces-first-patient-dosed-in-ascend-the-second-phase-3-pivotal-study-of-dt120-odt-in-major-depressive-disorder Tue, 12 May 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/227/definium-therapeutics-announces-first-patient-dosed-in-ascend-the-second-phase-3-pivotal-study-of-dt120-odt-in-major-depressive-disorder